Epidemiology of emerging pneumococcal drug resistance: Implications for treatment and prevention

Vaccine

Volumn 16, Issue 18, 1998, Pages 1693-1697

  Butler, Jay C ^a   Dowell, Scott F ^a   Breiman, Robert F ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN; CHLORAMPHENICOL; IMIPENEM; PENICILLIN G; PNEUMOCOCCUS VACCINE; RIFAMPICIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MENINGITIS; CHILD CARE; DRUG EFFICACY; DRUG UTILIZATION; HIGH RISK POPULATION; HUMAN; IMMUNIZATION; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TREATMENT INDICATION; TREATMENT PLANNING;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL VACCINES; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MICROBIAL; HUMANS; INCIDENCE; INFANT; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PNEUMONIA, PNEUMOCOCCAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0032211285     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00132-7     Document Type: Article

References (56)

1. 1 Marston, B.J., Plouffe, J.F. and File, T.M. et al. Incidence of community-acquired pneumonia requiring hospitalization: results of population-based active surveillance in Ohio. Arch. Int. Med. 1997, 157, 1709-1718.
2. 2 Schuchat, A., Deaver-Robinson, K. and Wenger, J.D. et al. Bacterial meningitis in the United States in 1995. N. Engl. J. Med. 1997, 337, 970-976.
3. 3 Del Beccaro, M.A., Mendelman, P.M. and Inglis, A.F. et al. Bacteriology of acute otitis media: a new perspective. J. Pediatr. 1992, 120, 81-84.
4. 4 Breiman, R.F., Spika, J.S., Navarro, V.J., Darden, P.M. and Darby, C.P. Pneumococcal bacteremia in Charleston County, South Carolina. Arch. Int. Med. 1990, 150, 1401-1405.
5. 5 Bennett, N.M., Buffington, J. and LaForce, F.M. Pneumococcal bacteremia in Monroe County, New York. Am. J. Public Health 1992, 82, 1513-1516.
6. 6 Hofmann, J., Cetron, M.S. and Farley, M.M. et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N. Engl. J. Med. 1995, 333, 481-486.
7. 7 Plouffe, J.F., Breiman, R.F. and Facklam, R.R. For the Franklin County Pneumonia Study Group. Bacteremia with Streptococcus pneumoniae in adults - implications for therapy and prevention. JAMA 1996, 275, 194-198.
8. 8 Cetron, M.S., Breiman, R.F. and Jorgensen, J.H. et al. Multisite population-based surveillance for drug-resistant Streptococcus pneumoniae. In: Abstracts of the 97 General Meeting of the American Society for Microbiology, May 4-8, 1997, Miami Beach, FL. Abstract C-283, p. 169.
9. 9 Nuorti, P., Vugia, D., Butler, J. and Reingold, A. Invasive pneumococcal disease among HIV-infected and uninfected residents of San Francisco, CA. In: Program and Abstracts of the 35th Annual Meeting of the Infectious Diseases Society of America, September 13-16, 1997, San Francisco, CA. Abstract 540.
10. 10 Davidson, M., Parkinson, A.J., Bulkow, L.R., Fitzgerald, M.A., Peters, H.V. and Parks, D.J. The epidemiology of invasive pneumococcal disease in Alaska, 1986-1990 - ethnic differences and opportunities for prevention. J. Infect. Dis. 1994, 170, 368-376.
11. 11 Cortese, M.M., Wolff, M., Almeido-Hill, J., Reid, R., Ketcham, J. and Santosham, M. High incidence rates of invasive pneumococcal disease in the White Mountain Apache population. Arch. Int. Med. 1992, 152, 2277-2282.
12. 12 Sutliff, W.D. and Finland, M. Type 1 pneumococcal infections with especial reference to specific serum treatment. N. Engl. J. Med. 1934, 210, 237-245.
13. 13 Tilghman, R.C. and Finland, M. Clinical significance of bacteremia in pneumococcal pneumonia. Arch. Int. Med. 1937, 59, 602-619.
14. 14 Feikin, D., Cetron, M. and Schuchat, A. et al. Multistate population-based assessment of drug resistant S. pneumoniae mortality. In: Program and Abstracts of the 35th Annual Meeting of the Infectious Diseases Society of America, September 13-16, 1997, San Francisco, CA. Abstract 48.
15. 15 Klugman, K.P. Pneumococcal resistance to antibiotics. Clin. Microbiol. Rev. 1990, 3, 171-196.
16. 16 Butler, J.C., Hofmann, J., Cetron, M.S., Elliott, J.A., Facklam, R.R. and Breiman, R.F. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System. J. Infect. Dis. 1996, 174, 986-993.
17. 17 Duchin, J.S., Breiman, R.F. and Diamond, A. et al. High prevalence of multi-drug resistant Streptococcus pneumoniae among children in a rural Kentucky community. Pediatr. Infect. Dis. J. 1995, 14, 745-750.
18. 18 Arnold, K.E., Leggiadro, R.J. and Breiman, R.F. et al. Risk factors for carriage of drug-resistant Streptococcus pneumoniae among children in Memphis, Tennessee. J. Pediatr. 1996, 128, 757-764.
19. 19 Dowell, S.F. and Schwartz, B. Resistant pneumococci: protecting patients through judicious use of antibiotics. Am. Fam. Phys. 1997, 55, 1647-1654.
20. 20 Nuorti, J.P., Butler, J.C., Crutcher, J.M. et al. An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents. N. Engl. J. Med. 1998, 338, 1861-1868.
21. 21 Craig, A.S., Erwin, P.C., Schaffner, W. et al. An outbreak of mutidrug resistant pneumococcal meningitis in a day care center. In: Program and Abstracts of the 35th Annual Meeting of the Infectious Diseases Society of America, San Francisco, CA, September 13-16, 1997. Abstract 32.
22. 22 Miller, J.L. and Lusk, F.B. Epidemic of Streptococcus pneumonia and empyema at Camp Dodge, IO. JAMA 1918, 71, 702-704.
23. 23 Hoge, C.W., Reichler, M.R. and Dominguez, E.A. et al. Epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail. Engl. J. Med. 1994, 331, 643-648.
24. 24 Musher, D.M., Groover, J.E. and Reichler, M.R. et al. Emergence of antibody of capsular polysaccharides of Streptococcus pneumoniae during outbreaks of pneumonia: association with nasopharyngeal colonization. Clin. Infect. Dis. 1997, 24, 441-446.
25. 25 Quick, R.E., Hoge, C.W., Hamilton, D.J., Whitney, C.J., Borges, M. and Kobayashi, J.M. Underutilization of pneumococcal vaccine in nursing homes in Washington State: report of a serotype-specific outbreak and a survey. Am. J. Med. 1993, 94, 149-152.
26. 26 Fiore, A., Inverson, C., Anderson, B. et al. Outbreak of pneumonia in a nursing home: antecedent human parainfluenza virus 1 infection may predispose to pneumonia. In: Program and Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LO, September 15-18, 1996. Abstract K-3.
27. 27 Cherian, T., Steinhoff, M.C., Harrison, L.H., Rohn, D., McDougal, L.K. and Dick, J. A cluster of invasive pneumococcal disease in young children in child care. JAMA 1994, 271, 695-697.
28. 28 Craig, A.S., Erwin, P.C., Schaffner, W. et al. An outbreak of multidrug resistant pneumococcal meningitis in a day care center. In: Program and Abstracts of the 35th Annual Meeting of the Infectious Diseases Society of America, San Francisco, CA, September 13-16, 1997. Abstract 32.
29. 29 Sloas, M.M., Barrett, F.F. and Chesney, P.J. et al. Cephalosporin treatment failure in penicillin-and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr. Infect. Dis. J. 1992, 11, 662-666.
30. 30 Friedland, I.R. and Klugman, K.P. Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis. Lancet 1992, 339, 405-408.
31. 31 John, C.C. Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review. Clin. Infect. Dis. 1994, 18, 188-193.
32. 32 Catalán, M.J., Fernández, J.M. and Vazquea, A. et al. Failure of cefotaxime in the treatment of meningitis due to relatively resistant Streptococcus pneumoniae. Clin. Infect. Dis. 1994, 18, 766-769.
33. 33 Guibert, M., Chahime, H., Petit, J., Odievre, M. and Labrune, P. Failure of cefotaxime treatment in two children with meningitis caused by highly penicillin-resistant Streptococcus pneumoniae. Acta Paediatrica 1995, 84, 831-833.
34. 34 Cleveland, K.O., Threlkeld, M.G., Tenover, F.C. and Leggiadro, R.J. Drug-resistant pneumococcal meningitis in an American adult. Clin. Infect. Dis. 1995, 20, 1572-1573.
35. 35 Pallares, R., Liñares, J. and Vadillo, M. et al. Resistance to penicillin and cephalosporins and mortality from severe pneumococcal pneumonia in Barcelona, Spain. 1995, N. Engl. J. Med. 333, 474-480.
36. 36 Friedland, I.R. Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease. Pediatr. Infect. Dis. J. 1995, 14, 885-890.
37. 37 American Academy of Pediatrics, Committee on Infectious Diseases. Therapy for children with invasive pneumococcal infections. Pediatrics 1997, 99, 289-299.
38. 38 Friedland, I.R., Paris, M.M., Ehrett, S., Mickey, S.M., Olsen, K.D. and McCracken, G.H. Jr. Evaluation of antimicrobial regimens for treatment of experimental penicillin and cephalosporin-resistant pneumococcal meningitis. Antimicrob. Agents Chemother. 1993, 37, 1630-1636.
39. 39 Friedland, I.R., Paris, M.M., Shelton, S. and McCracken, G.H. Jr. Time-kill studies of antimicrobial combinations against penicillin-resistant and susceptible Streptococcus pneumoniae. J. Antimicrob. Chemother. 1994, 34, 231-237.
40. 40 Klugman, K., Friedland, I.R. and Bradley, U.S. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob. Agents Chemother. 1995, 39, 1988-1992.
41. 41 McCaig, L.F. and Hughes, J.M. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA 1995, 273, 214-219.
42. 42 Kristinnson, K.G., Hjálmarsdóttir, M.A. and Gudnason, Th. Epidemiology of penicillin resistant pneumococcu in Iceland - hope for the future? In: Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, September 18, 1995. Abstract C-9.
43. 43 Seppälä, H., Klaukka, T. and Vuopio-Varkila, J. et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in Group A streptococci in Finland. N. Engl. J. Med. 1997, 337, 441-446.
44. 44 Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997, 46 (no. RR-8), 1-24.
45. 45 MacLeod, C.M., Hodges, R.G., Heidelberger, M. and Bernhard, W.G. Prevention of pneumococcal pneumonia by immunization with specific capsular polysaccharides. J. Exp. Med. 1945, 82, 445-465.
46. 46 Austrian, R., Douglas, R.M. and Schiffman, G. et al. Prevention of pneumococcal pneumonia by vaccination. Trans. Assoc. Am. Physicians 1976, 89, 184-189.
47. 47 Smit, P., Oberholzer, D., Hayden-Smith, S., Koornhof, H.J. and Hilleman, M.R. Protective efficacy of pneumococcal polysaccharide vaccines. JAMA 1997, 238, 2613-2616.
48. 48 Kaufman, P. Pneumonia in old age: active immunization against pneumonia with pneumococcus polysaccharide; results of a six year study. Arch. Int. Med. 1947, 79, 518-531.
49. 49 Broome, C.V. Efficacy of pneumococcal polysaccharide vaccines. Rev. Infect. Dis. 1981, 3, S82-S88.
50. 50 Simberkoff, M.S., Cross, A.P. and Al-Ibrahim, M. et al. Efficacy of pneumococcal vaccine in high-risk patients. Results of a veterans administration cooperative study. N. Engl. J. Med. 1986, 315, 1318-1327.
51. 51 Sims, R.V., Steinmann, W.C., McConville, J.H., King, L.R., Zwick, W.C. and Schwartz, U.S. The clinical effectiveness of pneumococcal vaccine in the elderly. Ann. Int. Med. 1988, 108, 653-657.
52. 52 Butler, U.C., Breiman, R.F., Campbell, J.F., Lipman, H.B., Broome, C.V. and Facklam, R.R. Polysaccharide pneumococcal vaccine efficacy: an evaluation of current recommendations. JAMA 1993, 270, 1826-1831.
53. 53 Shapiro, E.D., Berg, A.T. and Austrian, R. et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N. Engl. J. Med. 1991, 325, 1453-1460.
54. 54 Farr, B.M., Johnston, B.L. and Cobb, D.K. et al. Preventing pneumococcal bacteremia in patients at risk. Results of a matched case-control study. Arch. Int. Med. 1995, 155, 2336-2340.
55. 55 Sisk, J.E., Moskowitz, A.J. and Whang, W. et al. Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people. JAMA 1997, 278, 1333-1339.
56. 56 Centers for Disease Control and Prevention. Pneumococcal and influenza vaccination levels among adults aged ≥65 years - United States, 1995. MMWR 1997, 46, 913-919.